In the U.S., patients with coronavirus infection will be treated with a transfusion of blood plasma cured of the disease patients. The Fda’s Food and Drug Administration (FDA) said the available scientific evidence suggests that this treatment can be an effective method of disease control, and the potential benefits outweigh the potential risks.
“The released emergency permit for plasma treatment of recovered patients is a major achievement in President (Donald) Trump’s efforts to save lives from COVID-19,” U.S. Secretary of Health and Human Services Alex Azar said August 23.
This method of treatment has been tested for 70,000. Americans, the FDA noted.
On August 22, the American virologist stated that high population mobility and weak quarantine measures contributed to the wide spread of COVID-19 in the country. At the same time, the expert denied reports that the second wave of coronavirus will occur in the United States.
The United States ranks first in the world in the number of infected COVID-19.
According to Worldometer as of August 24, more than 5.8 million cases of infection have been detected in the country, of which more than 180,000 have been reported. Lethal. In total, more than 3.1 million patients with coronavirus have recovered in the country since the beginning of the pandemic.